Kiersten Stead

NILO Therapeutics is a biotechnology and therapeutics company.

Raised $9,600,002.00.

Radionetics Oncology is a pharmaceutical company that focuses on the discovery and development of novel radiotherapeutics.

Raised $82,500,000.00 from GordonMD Global Investments, 5AM Ventures, Crinetics Pharmaceuticals, DCVC Bio and Frazier Life Sciences.

Latus Bio focuses on developing innovative gene therapy candidates using precision delivery to enhance the lives of patients.

Raised $54,000,000.00 from The Children's Hospital of Philadelphia, Modi Ventures, 8VC, Gaingels, Samsung Life Science Fund, DCVC Bio and Ben Franklin Technology Partners.

Totus Medicines employs uses AI/ML and innovative DNA-encoded covalent library tech to discover small molecule medicines.

Raised $106,000,000.00 from Northpond Ventures, Regents of The University of Minnesota, Camford Capital and DCVC Bio.

MycoWorks is a biotechnology company that offers non-plastic and non-animal materials to the market.

Raised $187,000,000.00 from SOSV and IndieBio.

Stemson Therapeutics is a pre-clinical stage cell therapy company.

Raised $22,500,000.00 from Genoa Ventures, AbbVie and DCVC Bio.

Elo Life Systems is a biotechnology company that focuses on human health and wellness through food.

Raised $56,492,770.00 from Novo Holdings, DCVC Bio, Alexandria Venture Investments, Hanwha Next Generation Opportunity Fund, Accelr8, DCVC Bio, Novo Holdings and Accelr8.

Reinventing drug development from the ground up to make safe, effective oligonucleotide-based medicines possible on demand.

Raised $40,000,000.00 from DCVC Bio, BioBrit, Lux Capital, Casdin Capital and Alexandria Venture Investments.